Agilon Health (AGL) Cost of Revenue (2020 - 2026)

Agilon Health (AGL) has 7 years of Cost of Revenue data on file, last reported at $367.7 million in Q1 2026.

• Quarterly Cost of Revenue rose 358.52% year-over-year to $367.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 147.1% YoY) and the FY2025 annual result came in at $1.5 billion, down 7.69% from the prior year.
• Cost of Revenue slipped to $367.7 million in Q1 2026, from $384.3 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $1.0 billion in Q3 2023 to a low of -$552.9 million in Q4 2022.
• A 5-year average of $229.0 million and a median of $255.7 million in 2022 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue slumped 97.78% — and 2023, when it soared 11000.07%.
• Tracing AGL's Cost of Revenue over 5 years: stood at -$552.9 million in 2022, then soared by 151.13% to $282.7 million in 2023, then surged by 58.78% to $448.9 million in 2024, then dropped by 14.4% to $384.3 million in 2025, then retreated by 4.31% to $367.7 million in 2026.
• The last three Cost of Revenue figures came in at $367.7 million (Q1 2026), $384.3 million (Q4 2025), and $401.5 million (Q3 2025), per Business Quant data.